Cargando…
A Canadian single-centre experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for abdominal malignancies
BACKGROUND: Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has recently shown promise for the treatment of patients with various types of peritoneal carcinomatosis (PC). However, it is an extensive procedure that is associated with a variety of morbid...
Autores principales: | Nassabein, Rami, Younan, Rami, Loungarath, Rasmy, Mercier, Frederic, Dagbert, Francois, Aubin, Francine, Ayoub, Jean Pierre, Tehfé, Mustapha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188801/ https://www.ncbi.nlm.nih.gov/pubmed/35580884 http://dx.doi.org/10.1503/cjs.004320 |
Ejemplares similares
-
Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018) -
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014) -
Arterial thrombosis and coronavirus disease 2019 in a patient with cancer
por: Nassabein, Rami, et al.
Publicado: (2020) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019) -
COVID-19 Impact on Diagnosis and Staging of Colorectal Cancer: A Single Tertiary Canadian Oncology Center Experience
por: Castonguay, Mathias, et al.
Publicado: (2022)